Dissection of Macrophage Antifungal Activity against Aspergillus fumigatus

巨噬细胞抗烟曲霉抗真菌活性的剖析

基本信息

  • 批准号:
    8584085
  • 负责人:
  • 金额:
    $ 20.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-07 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Airborne conidia (spores) represent infectious propagules that are responsible for transmission of major human mycoses. Humans inhale ubiquitous Aspergillus fumigatus conidia on a daily basis. Conidial germination into tissue-invasive hyphae leads to invasive aspergillosis (IA), a devastating cause of infectious morbidity and mortality in patients with impaired respiratory innate immune function. Although conidial engulfment and killing are hallmarks of alveolar macrophage (AM) function during respiratory infection, antifungal effector mechanisms of these cells remain poorly defined, since assays that measure alveolar macrophage conidiacidial activity in the lung have been difficult to achieve. To dissect AM conidiacidal activity, we developed a fluorescent Aspergillus reporter (FLARE) strain that, upon conidial uptake, tags AMs with a fluorescent signature. Conidial killing induces a change in the fluorescence signature, enabling us to observe and quantify cell type-specific conidial killing in the lung and test tube. We harness the FLARE strain to demonstrate that AMs employ distinct conidiacidal mechanisms and implicate matrix metalloprotease 12 (MMP12) in this process. With this approach, we examine a model of AM function that integrates matrix metalloprotease 12 as a significant cytotoxic effector mechanism to achieve fungicidal activity. The hypothesis that underlies this proposal is that AM-specific factors - that include MMP12 - control A. fumigatus conidial germination at the earliest stages of respiratory fungal infection. The aims will (1) investigate MMP12 as a major effector of AM conidiacidal activity and (2) integrate alternate AM conidiacidal mechanisms using a functional RNAi-based approach. The experimental design incorporates both a candidate gene (MMP12) and a systematic discovery approach to dissect AM antifungal activity. These studies will define matrix metalloproteolytic activity as a potential novel antifungal effector mechanism and will identify candidate genes that regulate the full spectrum of AM conidiacidal activity.
描述(由申请方提供):气载分生孢子(孢子)代表负责传播主要人类真菌病的感染性繁殖体。人类每天都会吸入无处不在的烟曲霉分生孢子。分生孢子萌发成组织侵入性菌丝导致侵袭性曲霉病(IA),这是呼吸道先天免疫功能受损患者感染性发病率和死亡率的毁灭性原因。虽然分生孢子吞噬和杀伤是呼吸道感染过程中肺泡巨噬细胞(AM)功能的标志,但这些细胞的抗真菌效应机制仍不清楚,因为难以实现测量肺中肺泡巨噬细胞分生孢子活性的测定。为了剖析AM杀分生孢子活性,我们开发了一种荧光曲霉报告菌株(FLARE),在分生孢子摄取后,用荧光标记标记AM。分生孢子杀伤诱导荧光特征的变化,使我们能够观察和量化肺和试管中的细胞类型特异性分生孢子杀伤。我们利用FLARE菌株来证明AM采用不同的杀分生孢子机制,并在此过程中涉及基质金属蛋白酶12(MMP 12)。通过这种方法,我们研究了AM功能模型,该模型将基质金属蛋白酶12作为一种重要的细胞毒性效应机制,以实现杀真菌活性。该提议的假设是AM特异性因素(包括MMP 12)控制A。烟曲霉孢子萌发在呼吸道真菌感染的最早阶段。目的是(1)研究MMP 12作为AM杀分生孢子活性的主要效应子和(2)使用基于功能性RNAi的方法整合交替的AM杀分生孢子机制。实验设计结合了一个候选基因(MMP 12)和一个系统的发现方法来解剖AM抗真菌活性。这些研究将确定基质金属蛋白水解活性作为一种潜在的新型抗真菌效应机制,并将确定候选基因,调节全谱的AM杀分生孢子活性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TOBIAS M HOHL其他文献

TOBIAS M HOHL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TOBIAS M HOHL', 18)}}的其他基金

The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
  • 批准号:
    10415200
  • 财政年份:
    2021
  • 资助金额:
    $ 20.77万
  • 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
  • 批准号:
    10303678
  • 财政年份:
    2021
  • 资助金额:
    $ 20.77万
  • 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
  • 批准号:
    8467674
  • 财政年份:
    2011
  • 资助金额:
    $ 20.77万
  • 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
  • 批准号:
    8274640
  • 财政年份:
    2011
  • 资助金额:
    $ 20.77万
  • 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
  • 批准号:
    8735460
  • 财政年份:
    2011
  • 资助金额:
    $ 20.77万
  • 项目类别:
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS
对烟曲霉的免疫反应的启动
  • 批准号:
    10298001
  • 财政年份:
    2011
  • 资助金额:
    $ 20.77万
  • 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
  • 批准号:
    8848751
  • 财政年份:
    2011
  • 资助金额:
    $ 20.77万
  • 项目类别:
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS
对烟曲霉的免疫反应的启动
  • 批准号:
    10640120
  • 财政年份:
    2011
  • 资助金额:
    $ 20.77万
  • 项目类别:
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUS
对烟曲霉的免疫反应的启动
  • 批准号:
    10449393
  • 财政年份:
    2011
  • 资助金额:
    $ 20.77万
  • 项目类别:
Initiation of the Immune Response to Aspergillus fumigatus
对烟曲霉的免疫反应的启动
  • 批准号:
    8194743
  • 财政年份:
    2011
  • 资助金额:
    $ 20.77万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 20.77万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 20.77万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 20.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 20.77万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 20.77万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 20.77万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了